Century Therapeutics Correlations

IPSC Stock

USD 1.63 0.28 20.74%

The current 90-days correlation between Century Therapeutics and C4 Therapeutics is 0.36 (i.e., Weak diversification). The correlation of Century Therapeutics is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.

Century Therapeutics Correlation With Market

Very weak diversification

The correlation between Century Therapeutics and DJI is 0.4 (i.e., Very weak diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Century Therapeutics and DJI in the same portfolio, assuming nothing else is changed.

Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Century Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in state.

For information on how to trade Century Stock refer to our How to Trade Century Stock guide.

Moving together with Century Stock

0.64	FDMT	4D Molecular Therapeutics	Pair Corr
0.7	JNJ	Johnson Johnson Fiscal Year End 28th of January 2025	Pair Corr
0.81	MRK	Merck Company Fiscal Year End 6th of February 2025	Pair Corr
0.61	MREO	Mereo BioPharma Group	Pair Corr
0.77	NKTX	Nkarta Inc Buyout Trend	Pair Corr
0.74	PEPG	PepGen	Pair Corr
0.67	RGNX	Regenxbio	Pair Corr
0.78	ADAP	Adaptimmune Therapeutics	Pair Corr
0.72	BDTX	Black Diamond Therap	Pair Corr
0.74	COLL	Collegium Pharmaceutical	Pair Corr

Moving against Century Stock

0.69	BMY	Bristol Myers Squibb Aggressive Push	Pair Corr
0.57	NAMS	NewAmsterdam Pharma	Pair Corr
0.53	PHVS	Pharvaris BV	Pair Corr
0.42	ESLAW	Estrella Immunopharma	Pair Corr
0.38	PMVP	Pmv Pharmaceuticals	Pair Corr
0.31	LPTX	Leap Therapeutics	Pair Corr
0.71	CRVS	Corvus Pharmaceuticals	Pair Corr
0.7	AVTE	Aerovate Therapeutics	Pair Corr
0.63	SGMO	Sangamo Therapeutics Buyout Trend	Pair Corr
0.59	VREX	Varex Imaging Corp	Pair Corr
0.39	AGIO	Agios Pharm	Pair Corr

Related Correlations Analysis

	EWTX	CCCC	MLYS	CGEM	PASG	FIXX	GBIO	STOK	ERAS	NGM
EWTX		-0.31	0.66	-0.39	-0.67	-0.13	-0.44	-0.65	-0.19	0.0	EWTX
CCCC	-0.31		0.11	0.67	0.57	0.1	0.86	0.57	0.34	0.0	CCCC
MLYS	0.66	0.11		-0.13	-0.33	-0.12	0.02	-0.36	0.0	0.0	MLYS
CGEM	-0.39	0.67	-0.13		0.44	-0.03	0.7	0.6	0.27	0.0	CGEM
PASG	-0.67	0.57	-0.33	0.44		0.0	0.62	0.66	0.35	0.0	PASG
FIXX	-0.13	0.1	-0.12	-0.03	0.0		0.1	-0.24	-0.38	0.0	FIXX
GBIO	-0.44	0.86	0.02	0.7	0.62	0.1		0.48	0.11	0.0	GBIO
STOK	-0.65	0.57	-0.36	0.6	0.66	-0.24	0.48		0.66	0.0	STOK
ERAS	-0.19	0.34	0.0	0.27	0.35	-0.38	0.11	0.66		0.0	ERAS
NGM	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		NGM
	EWTX	CCCC	MLYS	CGEM	PASG	FIXX	GBIO	STOK	ERAS	NGM

Click cells to compare fundamentals

Check Volatility

Backtest Portfolio

Please upgrade your account to get full access to Macroaxis premium features

Correlation Matchups

Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.

High positive correlations

GBIO	+ 0.86	CCCC
GBIO	+ 0.7	CGEM
CGEM	+ 0.67	CCCC
MLYS	+ 0.66	EWTX
STOK	+ 0.66	PASG
ERAS	+ 0.66	STOK

High negative correlations

PASG	- 0.67	EWTX
STOK	- 0.65	EWTX
GBIO	- 0.44	EWTX
CGEM	- 0.39	EWTX
ERAS	- 0.38	FIXX
STOK	- 0.36	MLYS

Risk-Adjusted Indicators

There is a big difference between Century Stock performing well and Century Therapeutics Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Century Therapeutics' multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.

	Mean Deviation	Jensen Alpha	Sortino Ratio	Treynor Ratio	Semi Deviation	Expected Shortfall	Potential Upside	Value @Risk	Maximum Drawdown
EWTX	3.47	0.81	0.23	0.99	2.82	(4.05)	6.65	(4.70)	61.02
CCCC	3.62	(0.55)	0.00	(0.35)	0.00	0.00	8.59	(7.98)	23.66
MLYS	2.72	(0.12)	0.01	0.07	3.49	(2.75)	6.27	(5.79)	20.98
CGEM	2.89	(0.81)	0.00	(0.30)	0.00	0.00	5.88	(7.24)	17.85
PASG	5.07	0.03	(0.01)	0.20	5.92	(5.86)	10.00	(9.88)	25.50
FIXX	2.82	0.04	0.01	0.16	3.52	(3.25)	5.77	(5.61)	19.43
GBIO	4.07	(1.20)	0.00	(0.23)	0.00	0.00	9.35	(8.20)	25.48
STOK	2.61	(0.33)	0.00	(0.13)	0.00	0.00	4.68	(6.99)	21.35
ERAS	3.24	(0.04)	0.02	0.09	3.55	(3.75)	7.34	(5.19)	17.38
NGM	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00

Century Therapeutics Corporate Management

Michael Diem	Chief Officer	Profile
Morgan Conn	Chief Officer	Profile
Michael Naso	Senior Engineering	Profile
Nick MD	Senior Development	Profile
Kenneth JD	Head Compliance	Profile
Chad Cowan	Chief Officer	Profile

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC